Please assess the completion status of the following clinical trial:

Trial Title: Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically confirmed malignancy or lymphoproliferative disease including the following:~  * Nasopharyngeal carcinoma~ * Hodgkin's lymphoma~ * African Burkitt's lymphoma~ * T-cell non-Hodgkin's lymphoma~ * B-cell non-Hodgkin's lymphoma if Epstein Barr Virus (EBV) positive~ * Other lymphomas associated with immunodeficiency or immunosuppression, including AIDS-related lymphoma~ * B-cell lymphoproliferative disorders~* Monoclonal or oligoclonal B-cell lymphoid disease (no polyclonal disease)~* EBV positive by immunohistochemistry or in situ hybridization~  * Negative serology for EBV allowed~PATIENT CHARACTERISTICS:~Age:~* 3 and over~Performance status:~* Any status~Hematopoietic:~* Absolute granulocyte count at least 1,000/mm\^3~* Platelet count at least 50,000/mm\^3~Hepatic:~* Bilirubin no greater than 1.5 mg/dL~* Aminotransferase less than 2 times normal~Renal:~* Creatinine less than 3.0 mg/dL~* Creatinine clearance greater than 30 mL/min~Cardiovascular:~* No acute myocardial infarction within the past 6 months~* No atrial fibrillation within the past 6 months~Other:~* Not pregnant or nursing~* Negative pregnancy test~* Fertile patients must use effective contraception~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* Prior bone marrow or stem cell transplantation allowed~* No concurrent immunotherapy~* No concurrent interferon or tacrolimus~Chemotherapy:~* At least 3 weeks since prior chemotherapy (6 weeks for nitrosoureas and mitomycin) and recovered~* No concurrent cytotoxic chemotherapy~Endocrine therapy:~* No concurrent steroids~Radiotherapy:~* Recovered from prior radiotherapy~Surgery:~* Not specified

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).